Search results
Results From The WOW.Com Content Network
COVID-19. Pfizer. 3C-like protease inhibitor (Nirmatrelvir) / inhibition of metabolism of nirmatrelvir (ritonavir) Nevirapine. HIV. non- nucleoside reverse transcriptase inhibitor. Nitazoxanide. Broad-spectrum antiviral.
Antiretroviral drugs for HIV. Antiviral drugs are a class of medication used for treating viral infections. [1] Most antivirals target specific viruses, while a broad-spectrum antiviral is effective against a wide range of viruses. [2] Antiviral drugs are a class of antimicrobials, a larger group which also includes antibiotic (also termed ...
Vidarabine is an antiviral, active against herpes viruses, poxviruses, rhabdoviruses, hepadnaviruses and some RNA tumour viruses. A 3% ophthalmic ointment Vira-A is used in the treatment of acute keratoconjunctivitis and recurrent superficial keratitis caused by HSV-1 and HSV-2. [ 29]
Broad-spectrum antiviral drug. Broad-spectrum antivirals (BSAs) are a class of molecules or compounds, which inhibit the infection of multiple viruses from the same (intra-family BSAs) or different (inter-family BSAs) virus families. BSAs could be divided into experimental and investigational agents, and approved drugs.
Aciclovir, also known as acyclovir, [ 4] is an antiviral medication. [ 5] It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. [ 6] Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein–Barr virus infection. [ 6][ 7] It can be taken ...
[8] [11] [10] [17] It contains the antiviral medications nirmatrelvir and ritonavir and was developed by Pfizer. [8] [10] Nirmatrelvir inhibits SARS-CoV-2 main protease, while ritonavir is a strong CYP3A inhibitor, slowing down nirmatrelvir metabolism and therefore boosting its effect. [10] [18] It is taken by mouth. [10]
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bimonthly by International Medical Press. It was established in January 1990 and published by Blackwell Publishing until 1997. [1] The editor-in-chief is Hugh J. Field ( University of Cambridge ). The journal covers research on all aspects of the preclinical ...
Protease inhibitors ( PIs) are medications that act by interfering with enzymes that cleave proteins. Some of the most well known are antiviral drugs widely used to treat HIV/AIDS, hepatitis C and COVID-19. These protease inhibitors prevent viral replication by selectively binding to viral proteases (e.g. HIV-1 protease) and blocking ...